Avaí Bio and Austrianova have completed a Master Cell Bank of genetically modified cells overexpressing the α-Klotho protein, a key anti-aging factor, marking a major step toward clinical trials for cell-based therapies targeting aging and related diseases. This milestone supports the development of treatments for conditions like kidney disease, neurodegenerative disorders, and vascular diseases by restoring the 'longevity protein.' The global cell therapy market is expected to grow significantly, driven by advances in regenerative medicine and increasing demand for longevity and neurodegenerative disease treatments. Other biotech companies like Geron, BioAge Labs, Lineage Cell Therapeutics, and Fate Therapeutics are also progressing in clinical studies for therapies addressing blood cancer, inflammation, macular degeneration, and lupus nephritis, highlighting broad innovation in cell and gene therapies.
Mondelēz International's Board of Directors announced a regular quarterly dividend of $0.50 per share of Class A common stock. The dividend will be paid on July 14, 2026, to shareholders recorded by June 30, 2026. This move reflects the company's ong...
ADT Inc. introduced ADT Blu, a self-installed home security system that customers can set up quickly and manage via the ADT+ app. It offers flexible, modular security options without long-term contracts, combining convenience with integrated protecti...
State Street Global Advisors & Affiliates purchased 3,532 ordinary shares of DCC plc on May 19, 2026, at a price of €59.90 per share. This transaction increased their total holding to 1,189,358 shares, representing 1.3923% of the company's shares. Th...
Choice Hotels International announced a quarterly cash dividend of $0.2875 per share on its common stock, payable on July 15, 2026, to shareholders of record as of July 1, 2026. This dividend reflects the company's ongoing commitment to returning val...
Banzai International has reduced its debt to the lowest level since its December 2023 IPO, eliminating about $7.8 million in debt this year. CEO Joe Davy highlighted that this debt reduction enhances the company's financial flexibility and supports i...
